Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 1.950
-0.050 (-2.50%)
Aug 27, 2026, 4:08 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 726.74 million as of August 27, 2026. Its market cap has decreased by -76.60% in one year.
Market Cap
726.74M
Enterprise Value
202.77M
Revenue
374.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.95
ChartMarket Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 726.74M, a decrease of -89.11%. That is a compound annual growth rate of -49.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 726.74M | -55.95% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 996.59M |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 871.57M |
| JW (Cayman) Therapeutics Co. | 817.88M |
| 3D Medicines | 750.06M |
| Brii Biosciences | 743.46M |
| Wuhan YZY Biopharma | 639.70M |